                         SEQUENCE LISTING

<110>  CNRS
 
<120>  Procd de synthse de protines

<130>  33259 FR

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide X1

<400>  1

Gly Ile Leu Lys Glu Pro Val Gln Gly Ala 
1               5                   10  


<210>  2
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 9

<400>  2

Cys Ile Leu Lys Glu Pro Val His Gly Ala 
1               5                   10  


<210>  3
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 11a

<400>  3

Gly Ile Leu Lys Glu Pro Val Gln Gly Ala Cys His His Leu Glu Pro 
1               5                   10                  15      


Gly Gly Cys His His Leu Glu Pro Ala Gly Cys Ile Leu Lys Glu Pro 
            20                  25                  30          


Val His Gly Ala 
        35      


<210>  4
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 16a

<400>  4

Cys His His Leu Glu Pro Gly Gly Cys Ile Leu Lys Glu Pro Val His 
1               5                   10                  15      


Gly Ala 
        


<210>  5
<211>  94
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 29


<220>
<221>  VARIANT
<222>  (94)..(94)
<223>  Xaa is Lys biotinylated

<400>  5

Ala Ala Ala Ala Ala Lys Asp Tyr Ile Arg Asn Cys Ile Ile Gly Lys 
1               5                   10                  15      


Gly Arg Ser Tyr Lys Gly Thr Val Ser Ile Thr Lys Ser Gly Ile Lys 
            20                  25                  30          


Cys Gln Pro Trp Ser Ser Met Ile Pro His Glu His Ser Phe Leu Pro 
        35                  40                  45              


Ser Ser Tyr Arg Gly Lys Asp Leu Gln Glu Asn Tyr Cys Arg Asn Pro 
    50                  55                  60                  


Arg Gly Glu Glu Gly Gly Pro Trp Cys Phe Thr Ser Asn Pro Glu Val 
65                  70                  75                  80  


Arg Tyr Glu Val Cys Asp Ile Pro Gln Cys Ser Glu Val Xaa 
                85                  90                  


<210>  6
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 21


<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  Xaa is Asn-SEAoff in which SEAoff means bis(2-sulfanylethyl)amino
       cyclic

<400>  6

Ala Ala Ala Ala Ala Lys Asp Tyr Ile Arg Xaa 
1               5                   10      


<210>  7
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 22


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Xaa at position 1 is Cys(StBu) in which StBu means terbutylsulfenyl

<220>
<221>  VARIANT
<222>  (21)..(21)
<223>  Xaa at position 21 is Lys-SEAoff, in which SEAoff means 
       bis(2-sulfanylethyl)amino cyclic

<400>  7

Xaa Ile Ile Gly Lys Gly Arg Ser Tyr Lys Gly Thr Val Ser Ile Thr 
1               5                   10                  15      


Lys Ser Gly Ile Xaa 
            20      


<210>  8
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 25


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Xaa at position 1 is Cys(StBu) in which StBu means terbutylsulfenyl

<220>
<221>  VARIANT
<222>  (28)..(28)
<223>  Xaa at position 28 is Tyr-SEAoff in which SEAoff means 
       bis(2-sulfanylethyl)amino cyclic

<400>  8

Xaa Gln Pro Trp Ser Ser Met Ile Pro His Glu His Ser Phe Leu Pro 
1               5                   10                  15      


Ser Ser Tyr Arg Gly Lys Asp Leu Gln Glu Asn Xaa 
            20                  25              


<210>  9
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 27


<220>
<221>  VARIANT
<222>  (34)..(34)
<223>  Xaa is Lys biotinylated

<400>  9

Cys Arg Asn Pro Arg Gly Glu Glu Gly Gly Pro Trp Cys Phe Thr Ser 
1               5                   10                  15      


Asn Pro Glu Val Arg Tyr Glu Val Cys Asp Ile Pro Gln Cys Ser Glu 
            20                  25                  30          


Val Xaa 
        


